Home 3 › Forum › Scuola Biennale 2022 › DISCUSSIONE 7 › Rispondi a: DISCUSSIONE 7
Buongiorno,
anche a me è capitato di utilizzare i feromoni sintetici di una notissima casa produttrice.
La mia gatta Sookie non ha mai sopportato bene i viaggi in auto ed il trasportino.
Iniziava a miagolare nel momento stesso in cui si usciva dalla porta di casa e per tutto il tragitto ululava, miagolava e spesso defecava nel trasportino.
Il mio veterinario ha lo studio a circa 40 minuti da casa mia, quindi potete immaginare l’incubo per la gatta ed anche per noi.
La soluzione del veterinario (meravigliosa persona, professionale, empatico e molto attento… ma carente decisamente sotto certi consigli) è stata quella di provare i feromoni artificiali, quando avevo esposto il problema al telefono, in vista della prossima visita di controllo.
Ammetto che sono anche super quotati tra i frequentatori dei social, quindi da ingenua ho effettuato l’investimento.
Spruzzato nel trasportino prima del viaggio verso la clinica, piena di speranza ed aspettativa ho vissuto uno dei viaggi peggiori per Sookie.
E’ salito notevolmente il livello di disagio della gatta. Oltre ad ululare e piangere ininterrottamente per 40 minuti ha defecato e vomitato. (Mai successo prima)
Meno male che prima di un viaggio in auto non la facevo mai mangiare!
Ho immaginato che non fosse proprio la soluzione migliore, visto che il ritorno è stato altrettanto traumatico per lei. (Ovviamente vuoi non caricare la dose con un secondo spruzzo post veterinario?)
Mi rimaneva quindi una boccetta di feromoni inutilizzata, messa al sicuro nella dispensa.
Caso vuole che qualche mese dopo è approdato a casa nostra Thor.
Nella mia ignoranza ed ingenuità ho dato retta ai consigli sul web, facendo un disastroso inserimento.
E spruzzando i feromoni nel salotto: “Perché tutti dicono che funzionano!”.
Ovviamente Sookie si è innervosita tantissimo e ho subito archiviato la boccetta.
Solo durante il corso ho scoperto che la reazione ai feromoni artificiali è unica e diversa per ogni individuo.
E’ passato del tempo da allora e posso però dare un’opinione personale, sincera:
La reazione è unica e non sapremo mai in anticipo quale potrà essere, i feromoni artificiali sono sopravvalutati e grazie alla pubblicità che viene fatta le persone che non hanno voglia di intervenire in maniera pratica e corretta nei problemi dei loro gatti trovano una metodo facile e veloce. (Per loro)
Quelle stesse persone non aiutano gli altri dando un feedback errato ed una scorretta informazione.
Abbiamo testato però, con alcune conoscenti, che spruzzato sulla persona il feromone artificiale più famoso crea una sorta di calma e distensione nei soggetti umani più nervosi con cui entra in contatto.
Per quanto riguarda la ricerca personale, come Laura e Serena ho notato che sul web esiste una sorta di bolla in cui i pareri e le esperienze sono spesso filtrate e dirette dalla casa madre produttrice e non è facile imbattersi in articoli utili e soprattutto scientifici.
Ho preferito non percorrere la strada della casa madre, poiché sapevo che sarebbero stati filtrati e ho cercato direttamente attraverso fonti veterinarie internazionali.
Il sito inglese “The veterinary nurse” affermato e competente in campo medico veterinario internazionale riporta un articolo molto approfondito, partendo dalla nascita dei feromoni artificiali.
Nell’articolo (Di cui riporto i punti più salienti e purtroppo senza figure) viene spiegato come sono stati scoperti ed in seguito commercializzati, viene data una spiegazione sul funzionamento e sull’anatomia felina.
Alla fine dell’articolo sono esposte le conclusioni finali, in linea con il mio pensiero:
“ La feromonoterapia, in aggiunta a un’appropriata modifica comportamentale e ambientale, è un metodo sicuro, facile da applicare, basato sull’evidenza ed efficace sia per alleviare i segni comportamentali di stress che per prevenire i problemi comportamentali associati. In quanto tale, l’uso della feromonoterapia dovrebbe essere parte integrante della pratica degli animali da compagnia, sostenendo il benessere dei pazienti che potrebbero altrimenti essere a rischio di provare disagio e potenzialmente causare lesioni a se stessi, ad altri animali, al pubblico e al personale dello studio.”
What are pheromones?
Pheromones are biologically active semiochemicals (chemical signals from one organism to another capable of bringing about a change in the recipient organism); they are secreted from the body of one animal and result in a behavioural, hormonal or developmental change in another individual, of the same species (Wyatt, 2003). Pheromones normally consist of small chain fatty acids that form pro-pheromones that are secreted from sebaceous glands as products of metabolism. A binding protein (to enhance solubility within mucosal fluid) and a series of chemicals produced by the saprophytic organisms inhabiting the gland are added to this pro-pheromone, producing a pheromone ‘complex’ and giving the pheromone a ‘signature’ associated with its function and the individual producer (Hargrave, 2014).
How have pheromones been used commercially?
Pheromones have been successfully used to enhance commercial activity for centuries (Wyatt, 2003). Farmers have traditionally used pheromones to manipulate the behaviour of animals, for example in persuading ewes to accept orphan lambs. More recently, pheromones have been successfully used as a ‘greener’ alternative to control insect pests, to protect the honey bee, to reduce the distress of management techniques in fish farms and, over the last 25 years, in the management of stress experienced in commercial pig and rabbit units, animal laboratories and zoos. For approximately 20 years, pheromonotherapy has been available to the veterinary profession for the prevention and alleviation of stress experienced by the horse, rabbit, cat and dog.
What is pheromonotherapy?
Pheromonotherapy is the use of synthetic analogues of pheromones, that would normally be derived from natural bodily secretions, to modify the behaviour of an animal (Mills et al, 2013). The commercially available pheromono-therapy products are intended to alter an animal’s perception of the environment through the unconscious stimulation of brain circuits associated with natural pheromones (Landsberg, 2015). As pheromonotherapy uses synthetic analogues of pheromones normally associated with an enhanced concept of recognition and familiarity, the use of pheromonotherapy assists the animal in coping, reducing the likelihood of the animal experiencing the emotions of anxiety or fear and hence reducing distress and its associated behaviours. Pheromonotherapy works through altering an animal’s perception of its environment and as this response is unconscious, it removes the need for the use of methods of behavioural suppression, that might otherwise have been used by a family in its attempts to bring about behavioural change in their pet.
The main advantages of pheromonotherapy are:
• As the synthetic pheromones are effectively ‘messengers’ immediately released following their response at the VNO’s olfactory surface, they do not penetrate the animal
• Although it is impossible to say that a treatment is without risk, because of its mode of action (and wealth of research studies — CEVA Comprehensive References, 2014) there should be no toxic or side effects associated with pheromonotherapy. However, there have been a small number of reports that owners have shown specific chemical sensitivities on contact with carrier mediums, e.g. with diffusers (please refer to the manufacturer’s guidance sheets)
• The lack of systemic activity means that pheromone therapies are highly compatible with concurrent medication — including psychotropic medication
• In addition, pheromonotherapy is safe to use with very young, old or ill animals
• If a pet’s behaviour problem is associated with the environment, then other household pets are also likely to be similarly affected, to some extent. Pheromonotherapy can benefit other household pets, of the same species, not yet showing obvious signs of distress. If another species of pet is present within a home, the use of one species-specific product will not interfere with a product designed to aid another species
• Possibly most important to your clients, pheromonotherapy is easy to use and hence, once applied, owner compliance becomes less of a barrier to recovery.
However, there are inevitable limitations to the products efficacy:
• Expectations regarding effectiveness in preventative strategies have to be proportional to the nature, and level, of exposure to a potentially distress-inducing stimulus
• Therapy should never be specifically used to enable the continuance of poor husbandry techniques
• In the early stages of development of a problem pheromonotherapy has, in some cases (CEVA Comprehensive References, 2014) been shown to aid a spontaneous recovery. However, pheromonotherapy is primarily intended to be used as an adjunct to an appropriate behaviour modification plan designed by a clinical animal behaviourist (see Box 1 for registers of practitioners). Some cases will be sufficiently severe to require other pharmaceutical support in combination with pheromonotherapy
• The correct pheromonotherapy product must be selected, meaning that staff education is paramount to success
• Care must be taken to follow manufacturer’s guidelines regarding placement of devices to ensure that pets attempting to gain proximity to a device do not damage themselves or the client’s home (e.g. if a device is placed behind a piece of furniture, an animal may scratch at the item to enable access to the device)
• The correct amount of product must be present in the environment — it is important that manufacturer’s guidelines are followed to ensure that there is a sufficient concentration of product reaching the VNO for the organ to recognise the pheromone message and respond appropriately.
From the above, it is clear that there are considerable advantages to the preventative and therapeutic use of pheromonotherapy to both pet and owner (Landsberg, 2006). However, owner expectations must be carefully managed by staff promoting pheromone products (Mills, 2013), to prevent disappointment in the product and the potential for client loss of faith in the efficacy of advice provided by staff. In addition, poor sales advice may result in clients failing to follow-up disappointing results with further efforts to support the welfare of their pet.
Is pheromonotherapy similar to aromatherapy?
Aromotherapy relies on odours, especially essential oils, being detected by the main olfactory epithelium (Mills 2013). As shown in Figure 2, the behavioural results of odour chemicals, stimulating the main olfactory epithelium, rely largely on stimulating the conscious circuits of the brain and hence rely heavily on learned associations between the odour and a situation. In comparison, pheromonotherapy relies on the synthetic analogues of natural pheromones and their unconscious and predictable responses at the amygdala. As pheromonotherapy involves the receptor sites associated with an acceptance of familiarity and increased safety, resultant behavioural responses are specific and more predictable than those associated with aromotherapy.
Will clients see equivalent behaviour and welfare improvements from supplements or nutraceutical products?
There are a wide array of supplements, nutraceuticals and diets marketed and promoted for the reduction and eradication of stress-related behaviours in companion animals. The fact that these products are ‘natural’ can be very appealing to clients, who often fail to realise that there is a lack of quality, placebo-based trials of these products; nor are owners aware that such products may not have been quality controlled to the same level as pharmaceutical products. In addition, the potential side effects and toxicity of these products when combined with other similar products or prescribed medication, will be unknown (Baker et al, 2020).
When advising clients, veterinary staff have a responsibility to encourage clients to invest in products that have a scientific basis for their use and a proven effectiveness. Pheromonotherapy has over 25 years of research-based evidence (see CEVA Comprehensive References, 2014) to support its efficacy when used alongside appropriate environmental and behavioural management. In addition, pheromonotherapy does not require daily dosing of, or application to, an animal and is species-specific in its activity (compared with e.g. herbal diffusers being used within a home and potentially affecting both humans and other family pets).
How does pheromonotherapy help companion animals to cope in a domestic environment?
A concept of safety is important to any animal (Figure 4). Most basic to an animal’s capacity to function is that its physiological needs are met (Maslow, 1943; Mills, 2013). After this, safe access to resources, without a need for conflict, is essential to psychological and physical wellbeing. However, if an animal does not have a sense of safety within its environment — if it cannot gain safe access to its basic resource requirements or if social relationships within the home are unpredictable and inconsistent — then the animal is forced to divert an excess of energy into resolving these safety-related problems (Mills, 2013). This leaves little opportunity for the animal to build more extended social relationships or to develop a greater level of resilience within its wider environment. Pheromonotherapy, in conjunction with environmental strategies, assists in the development of a concept of familiarity and safety within an environment. However, pheromontherapy is intended to act as an adjunct to environmental and behavioural management changes that enable families to meet the welfare needs of their companion animal — for sources of guidance regarding such changes, please contact a Clinical Animal Behaviourist (Box 1).
Recent innervations in pheromone therapy
Until recently, the research and production of pheromono-therapy products have followed a similar pattern; decode the message of the pheromone, identify its composition, create a synthetic analogue that mimics the natural secretion of the animal and confirm its efficacy (Pageat, 2020). Further studies have established how natural pheromones can be modified by nature to improve their volatility and message strength and these enabled improvements to be made to the synthetic product. However, more recently, it has become possible to identify both the carrier protein for the feline pheromones within facial secretions, and to identify the 3D representation of the binding protein within the feline VMO for that carrier protein (Durairaj et al, 2019). This has opened up an entire new method of examining the gene bank for a species, identifying receptor sites and binding proteins and then, through computer imaging, creating the structures that bond to the binding proteins (Figure 5) and investigating their effects — all without the use of animals for experiments!
The future is bright for cats!
Today’s domestic cat shows only a modest number of changes in the feline genome from its pre-domestication, solitary ancestor (Sparkes, 2020a). Domestic cats remain autonomous, with many experiencing difficulties in living alongside humans and other cats (Pageat, 2020; Sparkes, 2020a), often resulting in feline behaviours that owners find difficult to cope with, such as urine marking and scratching. For approximately 25 years, synthetic analogues of the facial (F3) pheromone has been available as Feliway Classic to assist with this problem and, more recently, Feliway Friends (Ceva Anmal Health) (the synthetic format of the cat appeasing pheromone) has assisted with social conflict problems between cats in multicat homes. However, the recent research has produced a targeted product, in the form of Feliway Optimum (Ceva Animal Health), capable of providing a message that the environment is stable and safe and that the proximity of other cats can trigger a positive emotional response (Pageat, 2020). Although studies of the efficacy of the new pheromonotherapy product are, as yet, limited (De Jaeger et al, 2021), Sparkes (2020b) reports that following 28 days of use of the novel product there was a highly significant reduction in cases of feline problem urination, fear, scratching and social conflict with co-habiting cats.
Conclusion
Pheromonotherapy, as an adjunct to appropriate behavioural and environmental modification, is a safe, easy to apply, evidence-based and effective method of both alleviating the behavioural signs of distress and preventing associated behaviour problems. As such, the use of pheromonotherapy should be an integral part of companion animal practice, supporting the welfare of patients that might otherwise be at risk of experiencing distress and potentially causing injury to themselves, other animals, members of the public and practice staff.
